Your browser doesn't support javascript.
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience.
Rodríguez-Leor, Oriol; Cid-Álvarez, Belén; Pérez de Prado, Armando; Rossello, Xavier; Ojeda, Soledad; Serrador, Ana; López-Palop, Ramón; Martín-Moreiras, Javier; Rumoroso, José Ramón; Cequier, Ángel; Ibáñez, Borja; Cruz-González, Ignacio; Romaguera, Rafael; Moreno, Raúl; Villa, Manuel; Ruíz-Salmerón, Rafael; Molano, Francisco; Sánchez, Carlos; Muñoz-García, Erika; Íñigo, Luís; Herrador, Juan; Gómez-Menchero, Antonio; Gómez-Menchero, Antonio; Caballero, Juan; Ojeda, Soledad; Cárdenas, Mérida; Gheorghe, Livia; Oneto, Jesús; Morales, Francisco; Valencia, Félix; Ruíz, José Ramón; Diarte, José Antonio; Avanzas, Pablo; Rondán, Juan; Peral, Vicente; Pernasetti, Lucía Vera; Hernández, Julio; Bosa, Francisco; Lorenzo, Pedro Luís Martín; Jiménez, Francisco; Hernández, José M de la Torre; Jiménez-Mazuecos, Jesús; Lozano, Fernando; Moreu, José; Novo, Enrique; Robles, Javier; Moreiras, Javier Martín; Fernández-Vázquez, Felipe; Amat-Santos, Ignacio J; Gómez-Hospital, Joan Antoni.
  • Rodríguez-Leor O; Institut del Cor, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; Institut de Recerca en Ciències de la Salut Germans Trias i Pujol, Badalona, Barce
  • Cid-Álvarez B; Servicio de Cardiología, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain.
  • Pérez de Prado A; Servicio de Cardiología, Hospital de León, León, España.
  • Rossello X; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain; Servicio de Cardiología, Institut d'Investigació Sanitària de les Illes Balears (IdISBa), Hospital Universitari Son Espases, Palma de Mallorca, Islas Baleares, Spain; Centro de Investigación Biomédica en Red Enferm
  • Ojeda S; Servicio de Cardiología, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, Spain.
  • Serrador A; Servicio de Cardiología, Hospital Clínico de Valladolid, Valladolid, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.
  • López-Palop R; Servicio de Cardiología, Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain.
  • Martín-Moreiras J; Servicio de Cardiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.
  • Rumoroso JR; Servicio de Cardiología, Hospital de Galdakao-Usansolo, Galdakao, Vizcaya, Spain.
  • Cequier Á; Servicio de Cardiología, Hospital de Bellvitge-Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Ibáñez B; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain; Servicio de Cardiología, Hospital Universitario IIS-Fundación Jiménez Díaz, Madrid, Spa
  • Cruz-González I; Servicio de Cardiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.
  • Romaguera R; Servicio de Cardiología, Hospital de Bellvitge-Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Moreno R; Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.
  • Villa M; Hospital Universitario Virgen del Rocío.
  • Ruíz-Salmerón R; Hospital Universitario Virgen Macarena.
  • Molano F; Hospital Universitario Virgen de Valme.
  • Sánchez C; Hospital Universitario General de Málaga.
  • Muñoz-García E; Hospital Universitario Virgen de la Victoria.
  • Íñigo L; Hospital Costa del Sol.
  • Herrador J; Hospital Universitario de Jaén.
  • Gómez-Menchero A; Hospital Universitario Juan Ramón Jiménez.
  • Gómez-Menchero A; Eduardo Molina, Hospital Universitario Virgen de las Nieves.
  • Caballero J; Hospital Universitario San Cecilio.
  • Ojeda S; Hospital Universitario Reina Sofía.
  • Cárdenas M; Hospital Punta de Europa.
  • Gheorghe L; Hospital Universitario Puerta del Mar.
  • Oneto J; Hospital Universitario de Jerez de la Frontera.
  • Morales F; Hospital Universitario de Puerto Real.
  • Valencia F; Hospital Universitario Torrecárdenas.
  • Ruíz JR; Hospital Clínico Universitario Lozano Blesa.
  • Diarte JA; Hospital Universitario Miguel Servet.
  • Avanzas P; Hospital Universitario Central de Asturias.
  • Rondán J; Hospital Universitario de Cabueñes.
  • Peral V; Hospital Universitari Son Espases.
  • Pernasetti LV; Policlínica Nuestra Señora del Rosario.
  • Hernández J; Hospital Universitario Nuestra Señora de Candelaria.
  • Bosa F; Hospital Universitario de Canarias.
  • Lorenzo PLM; Hospital Universitario de Gran Canaria Doctor Negrín.
  • Jiménez F; Hospital Insular de Gran Canaria.
  • Hernández JMT; Hospital Universitario Marqués de Valdecilla de Santander.
  • Jiménez-Mazuecos J; Hospital General Universitario de Albacete.
  • Lozano F; Hospital General Universitario de Ciudad Real.
  • Moreu J; Complejo Hospitalario de Toledo.
  • Novo E; Hospital Universitario de Guadalajara.
  • Robles J; Hospital Universitario de Burgos.
  • Moreiras JM; Hospital de Universitario de Salamanca.
  • Fernández-Vázquez F; Hospital de León.
  • Amat-Santos IJ; Hospital Clínico Universitario de Valladolid, CIBERCV.
  • Gómez-Hospital JA; Hospital Universitari de Bellvitge.
Rev Esp Cardiol (Engl Ed) ; 73(12): 994-1002, 2020 Dec.
Article in English, Spanish | MEDLINE | ID: covidwho-752950
ABSTRACT
INTRODUCTION AND

OBJECTIVES:

The COVID-19 outbreak has had an unclear impact on the treatment and outcomes of patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess changes in STEMI management during the COVID-19 outbreak.

METHODS:

Using a multicenter, nationwide, retrospective, observational registry of consecutive patients who were managed in 75 specific STEMI care centers in Spain, we compared patient and procedural characteristics and in-hospital outcomes in 2 different cohorts with 30-day follow-up according to whether the patients had been treated before or after COVID-19.

RESULTS:

Suspected STEMI patients treated in STEMI networks decreased by 27.6% and patients with confirmed STEMI fell from 1305 to 1009 (22.7%). There were no differences in reperfusion strategy (> 94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P<.001) but showed no differences in the time from first medical contact to reperfusion. In-hospital mortality was higher during COVID-19 (7.5% vs 5.1%; unadjusted OR, 1.50; 95%CI, 1.07-2.11; P <.001); this association remained after adjustment for confounders (risk-adjusted OR, 1.88; 95%CI, 1.12-3.14; P=.017). In the 2020 cohort, there was a 6.3% incidence of confirmed SARS-CoV-2 infection during hospitalization.

CONCLUSIONS:

The number of STEMI patients treated during the current COVID-19 outbreak fell vs the previous year and there was an increase in the median time from symptom onset to reperfusion and a significant 2-fold increase in the rate of in-hospital mortality. No changes in reperfusion strategy were detected, with primary percutaneous coronary intervention performed for the vast majority of patients. The co-existence of STEMI and SARS-CoV-2 infection was relatively infrequent.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Registries / Disease Management / Pandemics / Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English / Spanish Journal: Rev Esp Cardiol (Engl Ed) Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Registries / Disease Management / Pandemics / Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English / Spanish Journal: Rev Esp Cardiol (Engl Ed) Year: 2020 Document Type: Article